Status:
NOT_YET_RECRUITING
Revealing Engagement Patterns Among Endometrial Cancer Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Endometrial Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study intends to investigate the personal experiences of endometrial cancer patients who take part in a separate clinical study including a specific medication intervention. The major focus will b...
Eligibility Criteria
Inclusion
- Patients diagnosed with endometrial cancer
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion
- Refusal of consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
- Any serious and/or unstable pre-existing medical disorders
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05998798
Start Date
September 1 2024
End Date
September 1 2026
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107